Impact of Left Ventricular Ejection Fraction on Clinical Outcomes in Bicuspid Aortic Valve Disease

The prognostic impact of left ventricular ejection fraction (LVEF) in patients with bicuspid aortic valve (BAV) disease has not been previously studied. The purpose of this study was to determine the prognostic impact of LVEF in BAV patients according to the type of aortic valve dysfunction. We retr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2022-09, Vol.80 (11), p.1071-1084
Hauptverfasser: Hecht, Sébastien, Butcher, Steele C, Pio, Stephan M, Kong, William K F, Singh, Gurpreet K, Ng, Arnold C T, Perry, Rebecca, Poh, Kian Keong, Almeida, Ana G, González, Ariana, Shen, Mylène, Yeo, Tiong Cheng, Shanks, Miriam, Popescu, Bogdan A, Gay, Laura Galian, Fijałkowski, Marcin, Liang, Michael, Tay, Edgar, Marsan, Nina Ajmone, Selvanayagam, Joseph, Pinto, Fausto, Zamorano, Jose L, Evangelista, Arturo, Delgado, Victoria, Bax, Jeroen J, Pibarot, Philippe
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The prognostic impact of left ventricular ejection fraction (LVEF) in patients with bicuspid aortic valve (BAV) disease has not been previously studied. The purpose of this study was to determine the prognostic impact of LVEF in BAV patients according to the type of aortic valve dysfunction. We retrospectively analyzed the data collected in 2,672 patients included in an international registry of patients with BAV. Patients were classified according to the type of aortic valve dysfunction: isolated aortic stenosis (AS) (n = 749), isolated aortic regurgitation (AR) (n = 554), mixed aortic valve disease (MAVD) (n = 190), or no significant aortic valve dysfunction (n = 1,179; excluded from this analysis). The study population was divided according to LVEF strata to investigate its impact on clinical outcomes. The risk of all-cause mortality and the composite endpoint of aortic valve replacement or repair (AVR) and all-cause mortality increased when LVEF was 
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2022.06.032